FUSED IMIDAZOLE DERIVATIVES USEFUL AS IDO INHIBITORS
Presently provided are IDO inhibitors and pharmaceutical compositions thereof, useful for modulating an activity of indoleamine 2,3-dioxygenase; treating indoleamine 2,3-dioxygenase (IDO) mediated inimunosuppression; treating a medical conditions that benefit from the inhibition of enzymatic activity of indoleamine-2,3-dioxygenase; enhancing the effectiveness of an anti-cancer treatment comprising administering an anti-cancer agent; treating tumor-specific immunosuppression associated with cancer; and treating immunosupression associated with an infectious disease.
-
Page/Page column 102; 104
(2012/11/06)
15-Cycloaliphatic derivatives of 13,14-didehydro-carboprostacyclins and process for their preparation
13, 14 didehydro-15 cyclic prostacyclins have been prepared.
-
(2008/06/13)
More Articles about upstream products of 41691-13-8